SCHEMBL3899486

SCHEMBL3899486

Cc1ccccc1CNC(=O)c1ccc(Cl)cc1NS(=O)(=O)C1=CC=CN2SNC=C12

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
CCKBR P32239 5/20 0.40
HPGD P15428 3/20 0.39
KDM4E B2RXH2 2/20 0.37
RCE1 Q9Y256 1/20 0.37
KCNA5 P22460 1/20 0.37
HTT P42858 1/20 0.37
SCN2A Q99250 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.36
CCKAR P32238 5/20 0.36
GPR27 Q9NS67 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
LMNA P02545 1/20 0.35
PPARG P37231 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3899498 0.92 ALDH1A1 (0.44) ALDH1A1CCKBRHPGDKDM4ERCE1
SCHEMBL3900875 0.91 CCKBR (0.40) ALDH1A1CCKBRHPGDKDM4ERCE1
SCHEMBL3907644 0.90 PRNP (0.43) ALDH1A1CCKBRHPGDKDM4ERCE1
SCHEMBL3900245 0.90 CCKBR (0.38) ALDH1A1CCKBRKDM4ERCE1KCNA5
SCHEMBL3901987 0.88 CCKBR (0.38) ALDH1A1CCKBRHPGDKDM4ERCE1
SCHEMBL3898564 0.88 CCKBR (0.38) CCKBRHPGDKCNA5CCKARPPARG
SCHEMBL3900371 0.88 CCKBR (0.40) CCKBRKCNA5CCKAR
SCHEMBL3901212 0.87 CCKBR (0.42) ALDH1A1CCKBRHPGDKDM4ERCE1
SCHEMBL3900373 0.87 CCKBR (0.45) CCKBRHPGDKCNA5CCKAR
SCHEMBL3903734 0.86 EPHX2 (0.37) ALDH1A1CCKBRKDM4ERCE1KCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7241759-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-10 US claimed
US-7550492-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2009-06-23 US disclosed
US-20070276016-A1 BENZO[1,2,5]THIADIAZOLE COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-29 US disclosed
US-7241759-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-10 US disclosed
EP-1675837-A2 BENZO [1,2,5] THIADIAZOLE COMPOUNDS AS CCK2 MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-07-05 EP disclosed
WO-2005012275-A2 BENZO [1, 2, 5] THIADIAZOLE COMPOUNDS AS CCK2 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2005-02-10 WO disclosed
US-20040224983-A1 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA, N.V. (BE) 2004-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276016-A1 BENZO[1,2,5]THIADIAZOLE COMPOUNDS CCKBR, CCKAR, GIPR ALDH1A1 3254/4885CCKBR 1/4885HPGD 1693/4885
US-20040224983-A1 Benzo[1,2,5]thiadiazole compounds CCKBR, CCKAR, BRSK2 ALDH1A1 1824/4885CCKBR 1/4885HPGD 1467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.